Gregory L. Shiferman

Insider Reports History

Entity
Individual
Location
C/O Sage Therapeutics, Inc., 55 Cambridge Parkway, Cambridge, MA
Signature
Brandon Marsh, attorney in fact for Gregory L. Shiferman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gregory L. Shiferman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sage Therapeutics, Inc. Senior Vice President, General Counsel and Secretary Common Stock 31K $214K $6.91 Apr 10, 2025 Direct
Sage Therapeutics, Inc. Senior Vice President, General Counsel and Secretary Stock Option (Right to buy) 28K Jan 16, 2025 Direct

Insider Reports Filed by Gregory L. Shiferman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SAGE Sage Therapeutics, Inc. Apr 10, 2025 2 -$1.22K 4 Apr 11, 2025 Senior Vice President, General Counsel and Secretary
SAGE Sage Therapeutics, Inc. Mar 24, 2025 1 -$649 4 Mar 26, 2025 Senior Vice President, General Counsel and Secretary
SAGE Sage Therapeutics, Inc. Feb 24, 2025 1 -$18.7K 4 Feb 25, 2025 Senior Vice President, General Counsel and Secretary
SAGE Sage Therapeutics, Inc. Feb 13, 2025 2 -$4.5K 4 Feb 14, 2025 Senior Vice President, General Counsel and Secretary
SAGE Sage Therapeutics, Inc. Jan 16, 2025 2 $0 4 Jan 21, 2025 Senior Vice President, General Counsel and Secretary
SAGE Sage Therapeutics, Inc. Dec 24, 2024 1 -$433 4 Dec 27, 2024 Senior Vice President, General Counsel and Secretary
SAGE Sage Therapeutics, Inc. Nov 1, 2024 2 $0 4 Nov 1, 2024 Senior Vice President, General Counsel and Secretary
SAGE Sage Therapeutics, Inc. Nov 1, 2024 0 $0 3 Nov 1, 2024 Senior Vice President, General Counsel and Secretary Exhibit Index: 24.1 Power of Attorney